Board of Directors

Åro Tilde Eide, Chair
Managing Director, Emilia GmbH
Åro Tilde Eide is a Managing Director of Emilia GmbH, a private wealth management company, and in addition is a member of MiracleFeet Germany’s Board of Directors. Åro has previously worked in market research for the Norwegian Trade Commission in New York, in strategic management planning in the oil industry for Esso Norge AS, and as Account Director in the Corporate Identity and Brand Building company Scandinavian Design Group and served as a Board Member of Stiftung Landheim Schondorf. Åro is a Norwegian citizen living in Munich with her husband Georg and their three children Beatrix, Ingerid, and Frederik, and holds a Bachelor of Business Degree from BI – Norwegian Business School and an MBA from INSEAD in France.

Mark Pavao, Treasurer
Managing Partner, Biotech Value Advisors
Mark Pavao has been a commercial leader in the global biopharma industry for 30+ years. Mark currently supports developing biotech companies with commercial and go-to-market strategy and tactical planning. Previous roles include President and CEO of R-Pharm US, President Bristol-Myers Squibb (BMS) / AstraZeneca Diabetes Alliance, President Emerging Markets Region at BMS, and SVP of Global Market Access and Pricing at BMS. Earlier, Mark held sales and marketing leadership roles at Bristol-Myers Squibb, SmithKline Beecham Pharmaceuticals, NitroMed Inc., and HeliosHealth. Mark has lived and/or worked in Brazil, Peru, Spain, Netherlands, Russia, India, China, Turkey, and the US. He received his MBA from Wharton and a BA from UNC-Chapel Hill, where he was a Morehead Scholar.

Joshua Hyman, MD, Medical Advisor
St. Giles Professor of Orthopedic Surgery, Columbia University
Dr. Josh Hyman is St. Giles Professor of Orthopedic Surgery at Columbia University, Attending Physician at New York-Presbyterian Hospital/Columbia University Medical Center, and Director of Pediatric Orthopedic Surgery. Dr. Hyman’s research focuses on methods of measuring quality of life in children. He is also actively involved in research trials on clubfoot, scoliosis and neuromuscular diseases in children. Josh completed his orthopedic surgical training at Harvard University and Massachusetts General Hospital.

Kris Bahner, Secretary
Senior Vice President, Global Corporate Affairs Officer, Kellanova
Kris Bahner leads Communications, Philanthropy, Sustainability, and Government Relations for Kellanova (formerly Kellogg Company). Kellanova is committed to creating Better Days for four billion people by the end of 2030 through Kellanova’s Better Days Promise global purpose platform addressing the interconnected issues of wellbeing, food security, and climate change. Kris, a member of Kellanova’s executive committee, was the chief architect of this award-winning platform. Prior to joining the company in 2006, Kris held a variety of corporate affairs roles with Kraft Foods as well as with Edelman and Powers Agency. She sits on several other boards including serving as President of Kellanova’s Fund and President of Kellanova’s 25-Year Employees’ Fund, Inc. She holds a Bachelor of Arts in communications and public relations from Miami University in Oxford, Ohio.

Chesca Colloredo-Mansfeld
Co-Founder and Former CEO, MiracleFeet
Chesca Colloredo-Mansfeld co-founded MiracleFeet in 2010. She helped to establish and then lead MiracleFeet as Executive Director and CEO until October 2022. During that time, organization grew to support 300+ clinics in over 30 countries, enrolling over 65,000 children in treatment, developed a low-cost brace and a sophisticated data collection and M&E system, both of which form critical elements of MiracleFeet’s replicable program model, and raised over $45M to support MiracleFeet’s global expansion. Her previous experience includes working for Boston Consulting Group, Goldman Sachs, internet start-ups eToys and CitySearch, Universities of Iowa and North Carolina business schools, and International Rescue Committee. Chesca is originally from England, grew up in Africa and Asia and spent time living and working in Pakistan and Ecuador. Chesca received an MBA from Stanford, where she was an Arjay Miller Scholar, and a BA in Economics and Political Science from UNC-Chapel Hill, where she was a Morehead-Cain Scholar. She and her husband, Rudi, have three children and live in Chapel Hill, NC.
Michelle Cooper
Speech/Language Pathologist
Michelle Cooper became passionate about helping children around the world after her third child, Braden, was born with clubfoot and treated in the United States by Dr. Jose Morcende. She holds a graduate degree from Florida Atlantic University and an undergraduate degree from the University of Michigan. A former speech-language pathologist and designer handbag buyer, Michelle currently resides in Long Island, New York.

Susan Eitel
Physical Therapist
Sue Eitel has over 35 years of international development experience focusing on rehabilitation and support for persons with disabilities. She began her international work as a Peace Corps volunteer in 1988 (teaching physical therapy courses at Chiang Mai University in Thailand) and has since worked with non-governmental organizations, USAID and the World Health Organization. She received her PT degree from Northwestern University and a Masters in Adult Education from Loyola University in Chicago. Sue’s older sister was born in Iowa City in 1951 and was one of the initial patients treated by Dr. Ponseti for clubfoot. Sue is semi-retired and lives in Boulder, Colorado.

Carol Karutu
Vice President, Programs, The END Fund
Carol Karutu previously served as Chief of Party for a USAID funded integrated health project implemented by IntraHealth International in Eastern Uganda. She is a 2014/2015 American Association of University Women (AAUW) International Fellow; a 2010 Boston University Distinguished Alumni Award recipient; a 2004 recipient of the Boston University Women’s Guild Award for Academic Excellence and a 2003 recipient of the PEO International Peace Scholarship. Carol received her Doctorate in Public Health and Master’s in Public Health from Boston University School of Public Health and a Bachelor of Science from Jomo Kenyatta University of Agriculture and Technology in Kenya.

Jackie Klaber
Managing Director, Rockefeller Capital Management
Jackie Klaber is a Managing Director and Head of Direct and Co-Investments at Rockefeller Capital Management, a global family office that began with John D. Rockefeller in 1882. Jackie is responsible for sourcing, vetting, and structuring differentiated private investment opportunities for the firm’s clients. Jackie previously worked at Goldman Sachs & Co. in the Alternative Investments & Manager Selection division. Jackie has degrees from Yale University, Columbia University, as well as Yale Law School where she completed a J.D./M.B.A. and served as an editor of The Yale Law Journal. She serves on the Board of the Yale Law School Fund and the Yale University Council.

Katja Markus
Katja was previously Head of Marketing for Mercateo – Europe’s leading online procurement provider. Having subsequently moved from business to charity, she was in a leadership role with Science Lab, a German organization fostering children’s interest in natural sciences. As a mother of three, she witnessed firsthand the magic that learning adds to a child’s life.
Katja also serves as a board member of Lotus Group and the Next Generation Foundation, a Swiss foundation supporting teenagers and young adults in becoming entrepreneurs and building their own businesses. Katja holds an MA and BA in Business Administration and Romance Studies from the University of Mannheim/Germany and the Institute Commercial De Nancy/France.

Greg Schott
Former CEO, MuleSoft
Greg’s career has been primarily in high tech. He was the CEO of MuleSoft from 2009 to 2019 and before that served as Senior Vice President of Marketing at SpringSource. He also served as Senior Vice President of Marketing and Vice President of Corporate Development at Agile Software. Before Agile, Greg served as Vice President of Marketing and Vice President of Operations at DG Systems and was previously with The Boston Consulting Group. Greg currently serves on the boards of Confluent and Pendo. He holds an MBA from Stanford and a BS in Mechanical Engineering from North Carolina State University.

Daphne de Souza Lima Sorensen
Chief Executive Officer (CEO), MiracleFeet
Daphne de Souza Lima Sorensen has 20 years’ experience in international development, social justice and child and human rights, leading teams across Latin America and Africa. She oversees global operations and staff, adding strategic leadership capacity to MiracleFeet’s growing team and impact. Daphne joined MiracleFeet from the Lumos Foundation, where she served as regional director for Latin America & Caribbean programs. For more than a decade prior, she held leadership roles at Save the Children—as country director in Bolivia and provincial program manager in Mozambique—and CARE as program coordinator in Brazil. She has also lived and worked in Uganda, Angola, Guatemala, Panama, and El Salvador. Daphne earned her master’s degree in Leadership from Duquesne University and bachelor’s in International Studies and Development and Economics from American University.
In addition to our current Board of Directors, we would also like to thank the following people who played important roles in creating and building MiracleFeet, many of whom also served as Board members:
Roger Berman (Co-Founder)
Bridget Ryan Berman (Co-Founder)
Hans Dekker
Andy Cohen
Jarret Fass
Glen MacDonald
Sarita Narson Jairath
Kunal Premnarayen
Rodger Raderman
Steve Sadove
Garth Saloner
Jennifer Tye
"I’ve watched MiracleFeet transform lives
…and it’s thrilling.”
Nicholas Kristof, The New York Times
Get Involved